Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: levocetirizine dihydrochloride

Summary for Generic Name: levocetirizine dihydrochloride

Drug Master File Entries: see list12
Suppliers: see list6
Therapeutic Class:Respiratory Tract Agents

Pharmacology for Ingredient: levocetirizine dihydrochloride

Clinical Trials for: levocetirizine dihydrochloride

Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses
Status: Completed Condition: Chronic Urticaria

Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
Status: Completed Condition: Perennial Allergic Rhinitis

Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema
Status: Completed Condition: Dermatitis; Eczema

Omnaris Versus Levocetirizine Phase 4 Study
Status: Completed Condition: Allergic Rhinitis

Pharmacokinetic Study of Levocetirizine Oral Solution
Status: Completed Condition: Rhinitis, Allergic, Perennial and Seasonal

Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition
Status: Completed Condition: Fed

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics
Status: Completed Condition: Rhinitis

Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions
Status: Completed Condition: Healthy

The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
Status: Terminated Condition: Rhinitis; Urticaria

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
Status: Completed Condition: Allergic Rhinitis; Chronic Urticaria

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Apotex Inc
levocetirizine dihydrochloride
SOLUTION;ORAL202915Aug 21, 2014RXNo<disabled>
L Perrigo Co
levocetirizine dihydrochloride
SOLUTION;ORAL091263Nov 7, 2011RXNo<disabled>
Taro Pharm Inds
levocetirizine dihydrochloride
SOLUTION;ORAL202673Jul 26, 2013RXNo<disabled>
Ucb Inc
levocetirizine dihydrochloride
SOLUTION;ORAL022157Jan 28, 2008RXYes5,698,558*PED<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology